Arrowhead Pharmaceuticals Inc.
ARWR:NASDAQ
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.
Streetwise Company Fact Sheet2024/12/22 11:35:49
(ARWR:NASDAQ)
Analyst coverage
| H.C. Wainwright & Co. — Patrick Trucchio |
| H.C. Wainwright & Co. — Patrick Trucchio |
Streetwise Reports Articles
| 07/23/2024 - View Article |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
